Drug-labels.com

Ran-Telmisartan: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
40 mg, 80 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Ran-Telmisartan

ABOUT THIS MEDICATION

What the medication is used for:

  • To treat high blood pressure

What it does:

RAN-TELMISARTAN is an angiotensin receptor blocker (ARB). You can recognize an ARB because its medicinal ingredient ends in “- SARTAN”.

This medicine does not cure your disease. It helps to control it. Therefore, it is important to continue taking RAN-TELMISARTAN regularly even if you feel fine.

When it should not be used:

Do not take RAN-TELMISARTAN if you:

  • Are allergic to telmisartan or to any non-medicinal ingredient in the formulation.
  • Have experienced an allergic reaction with swelling of the face, lips, tongue, throat, or sudden difficulty breathing or swallowing to any ARB. Be sure to tell your doctor, nurse, or pharmacist that this happened to you.
  • Are pregnant or intend to become pregnant. Taking RAN-TELMISARTAN during pregnancy can cause injury and even death to your baby.

  • Are breastfeeding. It is possible that RAN- TELMISARTAN passes into breast milk.
  • Are allergic to some sugars (fructose and/or sorbitol intolerant).
  • Are already taking a blood pressure-lowering medicine that contains aliskiren (such as Rasilez) and you have diabetes or kidney disease.

What the medicinal ingredient is:

Telmisartan USP

What the non-medicinal ingredients are:

Magnesium stearate, meglumine, povidone, sodium hydroxide and sorbitol

What dosage forms it comes in:

Tablets: 40 mg and 80 mg

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions - Pregnancy

RAN-TELMISARTAN should not be used during pregnancy. If you discover that you are pregnant while taking RAN-TELMISARTAN, stop the medication and please contact your doctor, nurse, or pharmacist as soon as possible.

Before you use RAN-TELMISARTAN talk to your doctor or pharmacist if you:

  • Have experienced an allergic reaction to any drug used to lower blood pressure.
  • Have narrowing of a heart valve, diabetes, liver or kidney disease, heart or blood vessel disease.
  • Are dehydrated or if you suffer from excessive vomiting, diarrhea, or sweating.
  • Are taking a medicine that contains aliskiren, such as Rasilez, used to lower high blood pressure. The combination with RAN-TELMISARTAN is not recommended.
  • Are taking an angiotensin-converting-enzyme inhibitor (ACEI).
  • Are taking a salt substitute that contains potassium, potassium supplements, or a potassium-sparing diuretic (a specific kind of “water pill” that makes your body keep potassium).
  • Are on a low salt diet.
  • Are on dialysis.
  • Are less than 18 years old.
  • Have been told by your doctor that you have an intolerance to some sugars.

Before you perform tasks which require special attention (driving a car or operating dangerous machinery), wait until you know how you respond to RAN-TELMISARTAN. Dizziness, lightheadedness, or fainting can especially occur after the first dose and when the dose is increased.

INTERACTIONS WITH THIS MEDICATION

As with most medicines, interactions with other drugs are possible. Tell your doctor, nurse, or pharmacist about all the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with RAN-TELMISARTAN:

  • Blood pressure lowering drugs, including diuretics (“water pills”), aliskiren-containing products (e.g. Rasilez), or angiotensin-converting-enzyme inhibitors (ACEI).
  • Lithium, used to treat mood disorder.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) used to reduce pain and swelling. Examples include acetylsalicylic acid (ASA), celecoxib, naproxen and ibuprofen.
  • Digoxin to treat many heart conditions.
  • Warfarin, used to prevent blood clots (blood thinner).
IMPORTANT: PLEASE READ

PROPER USE OF THIS MEDICATION

Take RAN-TELMISARTAN exactly as prescribed. It is recommended to take your dose at about the same time everyday with or without food, but it should be taken the same way each day.

Do not stop taking your medication before informing your doctor, nurse, or pharmacist.

Usual adult dose:

The recommended dose of RAN-TELMISARTAN is 80 mg once daily. Your doctor may prescribe 40 mg once daily if you have liver disease.

Overdose:

If you think you have taken too much RAN-TELMISARTAN contact your doctor, nurse, pharmacist, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed dose:

If you have forgotten to take your dose during the day, carry on with the next one at the usual time. Do not double dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Side effects may include:

  • back or leg pain, muscle cramps, joint pain, muscle spasms
  • headache, anxiety
  • diarrhea, constipation, nausea, vomiting, upset stomach, abdominal pain, flatulence
  • dry mouth
  • rash, eczema, skin eruptions
  • drowsiness, insomnia, fatigue
  • visual disturbances
  • upper respiratory infection

If any of these affects you severely, tell your doctor, nurse or pharmacist.

RAN-TELMISARTAN can cause abnormal blood test results. Your doctor will decide when to perform blood tests and will interpret the results.

IMPORTANT: PLEASE READ

SERIOUS SIDE EFFECTS, HOW OFTEN THEY

HAPPEN AND WHAT TO DO ABOUT THEM

Symptom / effectTalk with your doctor, nurse or pharmacistStop taking drug and seek immediate medical help
Only if sever eIn all case s

Very

Common

Chest pain√
CommonLow Blood Pressure: dizziness, fainting, lightheadedness√
Shortness of breath√
Uncommo nDepression: Low mood, loss of interest in activities, change in appetite and sleep patterns√

Kidney Disorder:

Change in frequency of urination, nausea, vomiting, swelling of extremities, fatigue

√
Increased levels of potassium in the blood: Irregular heartbeats, muscle weakness and generally feeling unwell√
Urinary Tract Infections (Cystitis): Frequent or painful urination, feeling unwell√
Rare

Liver disorder:

Yellowing of the skin or eyes, dark urine, abdominal pain, nausea, vomiting, loss of appetite

√

This is not a complete list of side effects. For any unexpected effects while taking RAN-TELMISARTAN, contact your doctor, nurse or pharmacist.

HOW TO STORE IT

RAN-TELMISARTAN tablets should be stored at room temperature 15° C - 30° C. Tablets should not be removed from blisters until immediately prior to administration. Avoid excessive heat and moisture.

Keep out of reach and sight of children and pets.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

------------------------------------------------------------------------

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form

and:

-Fax toll-free to 1-866-678-6789, or

-Mail to: Canada Vigilance Program

Health Canada

Postal Locator 0701E

Ottawa, Ontario K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting the sponsor, Ranbaxy Pharmaceuticals Canada Inc. at:

1-866-840-1340.

RANBAXY

Ranbaxy Pharmaceuticals Canada Inc.

2680 Matheson Blvd. E., Suite 200

Mississauga, Ontario

L4W 0A5

Last revised: January 21, 2014

SERIOUS SIDE EFFECTS, HOW OFTEN THEY

HAPPEN AND WHAT TO DO ABOUT THEM

Symptom / effectTalk with your doctor, nurse or pharmacistStop taking drug and seek immediate medical help
Only if severeIn all cases
Low blood sugar: Shaky, irregular heartbeat, sweating, hunger, dizziness (in diabetic patients)√
Unknown

Allergic Reaction:

Rash, hives, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing (potentially with fatal outcome)

√
Sepsis (blood poisoning): Chills, confusion, fever or low body temperature, shakiness, irregular heartbeat (including fatal outcome)√
Rhabdomyolysis: Muscle pain that you cannot explain, muscle tenderness or weakness or dark brown urine√
IMPORTANT: PLEASE READ

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02395401

Revision date stated in the text: January 21, 2014

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ran-Telmisartan

Rx or OTC
Prescription (Rx)?
DIN 02395401, 02395428
Schedule(s) PRESCRIPTION
Active ingredient(s) Telmisartan
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09C Angiotensin II receptor blockers (ARBs), plain
        1. C09CA Angiotensin II receptor blockers (ARBs), plain
          1. C09CA07 Telmisartan
Company RANBAXY PHARMACEUTICALS CANADA INC.
Current status Cancelled Post Market
Current status date December 20, 2022
Strengths and forms
DIN Strength Dosage form(s) Current status
02395401 40 MG Tablet Cancelled Post Market December 20, 2022
02395428 80 MG Tablet Cancelled Post Market December 20, 2022

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.